[1]
2024. Bimekizumab Efficacy Through 3 Years in Patients with Moderate to Severe Plaque Psoriasis: Long-term Pooled Analysis from BE BRIGHT. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s307. DOI:https://doi.org/10.25251/skin.8.supp.307.